• Je něco špatně v tomto záznamu ?

Linear Low-Intensity Extracorporeal Shockwave Therapy as a Method for Penile Rehabilitation in Erectile Dysfunction Patients after Radical Prostatectomy: A Randomized, Single-Blinded, Sham-Controlled Clinical Trial

I. Motil, D. Macik, K. Sramkova, J. Jarkovsky, T. Sramkova

. 2022 ; 106 (10) : 1050-1055. [pub] 20220810

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033380

INTRODUCTION: The objective of this study was to investigate the effect and feasibility of linear low-intensity extracorporeal shockwave therapy (LI-LiESWT) as a penile rehabilitation method for erectile dysfunction (ED) after bilateral nerve-sparing (NS) radical prostatectomy (RP). METHODS: Patients who had undergone bilateral NS RP (either radical retropubic prostatectomy or robot-assisted laparoscopic RP), 3 or more months prior to the study, and who had no ED preoperatively and were suffering from mild to severe postoperative ED were included in the study. Four treatments were given over a 4-week period, using the PiezoWave2 device with a linear shockwave applicator and the linear shockwave tissue coverage (LSTC-ED®) technique. If the improvement in erectile function was still considered insufficient (less than an IIEF-5 score of 22-25) at 2 months after the start of LI-LiESWT, penile rehabilitation was supplemented by pharmacological penile rehabilitation. The final effect of treatment was evaluated after 12 months. The main outcome measure was changes in the five-item International Index of Erectile Function (IIEF-5) score. RESULTS: Between September 2019 and September 2020, a total of 40 patients were included in the study and randomly divided into 2 groups: treatment group and sham group. Eight patients were excluded from the study and were not evaluated due to other conditions which required additional treatment (COVID-19 disease, postoperative incontinence, urethral stricture, and ischemic stroke). Thirty-two patients were included in the final analysis: 16 in the control group and 16 in the intervention group. At 6 months from the end of treatment, patients in both the treatment and the sham group achieved physiological IIEF-5 values, and the beneficial effect persisted for 12 months after the end of treatment. CONCLUSIONS: LI-LiESWT using the LSTC-ED® technique is a suitable and safe method for penile rehabilitation in patients with ED after bilateral NS RP, not only because of the vasculogenic effect of LI-LiESWT but also because of its neuroprotective and/or regenerative effects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033380
003      
CZ-PrNML
005      
20230131150802.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000525973 $2 doi
035    __
$a (PubMed)35947945
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Motil, Igor $u Urology/Andrology Center, Campus Klinika, Brno, Czechia
245    10
$a Linear Low-Intensity Extracorporeal Shockwave Therapy as a Method for Penile Rehabilitation in Erectile Dysfunction Patients after Radical Prostatectomy: A Randomized, Single-Blinded, Sham-Controlled Clinical Trial / $c I. Motil, D. Macik, K. Sramkova, J. Jarkovsky, T. Sramkova
520    9_
$a INTRODUCTION: The objective of this study was to investigate the effect and feasibility of linear low-intensity extracorporeal shockwave therapy (LI-LiESWT) as a penile rehabilitation method for erectile dysfunction (ED) after bilateral nerve-sparing (NS) radical prostatectomy (RP). METHODS: Patients who had undergone bilateral NS RP (either radical retropubic prostatectomy or robot-assisted laparoscopic RP), 3 or more months prior to the study, and who had no ED preoperatively and were suffering from mild to severe postoperative ED were included in the study. Four treatments were given over a 4-week period, using the PiezoWave2 device with a linear shockwave applicator and the linear shockwave tissue coverage (LSTC-ED®) technique. If the improvement in erectile function was still considered insufficient (less than an IIEF-5 score of 22-25) at 2 months after the start of LI-LiESWT, penile rehabilitation was supplemented by pharmacological penile rehabilitation. The final effect of treatment was evaluated after 12 months. The main outcome measure was changes in the five-item International Index of Erectile Function (IIEF-5) score. RESULTS: Between September 2019 and September 2020, a total of 40 patients were included in the study and randomly divided into 2 groups: treatment group and sham group. Eight patients were excluded from the study and were not evaluated due to other conditions which required additional treatment (COVID-19 disease, postoperative incontinence, urethral stricture, and ischemic stroke). Thirty-two patients were included in the final analysis: 16 in the control group and 16 in the intervention group. At 6 months from the end of treatment, patients in both the treatment and the sham group achieved physiological IIEF-5 values, and the beneficial effect persisted for 12 months after the end of treatment. CONCLUSIONS: LI-LiESWT using the LSTC-ED® technique is a suitable and safe method for penile rehabilitation in patients with ED after bilateral NS RP, not only because of the vasculogenic effect of LI-LiESWT but also because of its neuroprotective and/or regenerative effects.
650    12
$a COVID-19 $7 D000086382
650    12
$a erektilní dysfunkce $x etiologie $x terapie $7 D007172
650    12
$a léčba mimotělní rázovou vlnou $x škodlivé účinky $7 D000074059
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a erekce penisu $7 D010410
650    _2
$a prostatektomie $x škodlivé účinky $x metody $7 D011468
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Macik, Daniel $u Urology Department of Masaryk Memorial Cancer Institute (MMCI), Brno, Czechia
700    1_
$a Sramkova, Katerina $u Urology Department, St. Anna Hospital, Brno, Czechia
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses (IBA FM MU), Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Sramkova, Tatjana $u Urology Department of Masaryk Memorial Cancer Institute (MMCI), Brno, Czechia $u Department of Urology and Institute of Sexology, General University Hospital, First Faculty of Medicine, Charles University Prague, Prague, Czechia $u Department of Sexology, University Hospital and Department of Traumatology, Masaryk University, Brno, Czechia
773    0_
$w MED00004616 $t Urologia internationalis $x 1423-0399 $g Roč. 106, č. 10 (2022), s. 1050-1055
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35947945 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131150758 $b ABA008
999    __
$a ok $b bmc $g 1891908 $s 1184715
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 106 $c 10 $d 1050-1055 $e 20220810 $i 1423-0399 $m Urologia internationalis $n Urol Int $x MED00004616
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

    Možnosti archivace